Literature DB >> 16825019

Accumulation of indoxyl sulfate in OAT1/3-positive tubular cells in kidneys of patients with chronic renal failure.

Kentaro Taki1, Sakurako Nakamura, Marius Miglinas, Atsushi Enomoto, Toshimitsu Niwa.   

Abstract

Indoxyl sulfate shows nephrotoxicity and is a stimulating factor for progression of chronic renal failure (CRF). Indoxyl sulfate is taken up by renal proximal tubular cells through organic anion transporters 1 and 3 (OAT1/3), and is accumulated in the renal proximal tubular cells of uremic rats. To determine whether indoxyl sulfate is accumulated in human OAT1/3 (hOAT1/3)-positive renal proximal tubular cells, localization of indoxyl sulfate and hOAT1/3 in the kidneys of CRF patients was determined by immunohistochemistry. Kidney samples were obtained by autopsy from 9 CRF patients (mean serum creatinine 4.7 mg/dL, ranging from 2.0 to 14.5 mg/dL) and 9 patients with non-kidney disease (mean serum creatinine 0.6 mg/dL, ranging from 0.4 to 0.9 mg/dL). Immunohistochemistry was performed using antibodies against indoxyl sulfate, hOAT1, and hOAT3. Indoxyl sulfate was localized in the hOAT1- and hOAT3-positive renal tubular cells in the kidneys of CRF patients. The indoxyl sulfate-positive area in the kidneys was markedly increased in the kidneys of CRF patients compared with patients with non-kidney disease. The indoxyl sulfate-positive area was positively correlated with serum creatinine. In conclusion, in CRF patients, indoxyl sulfate is accumulated in the tubular cells with hOAT1 and/or hOAT3 localized at the basolateral membrane. The extent of indoxyl sulfate accumulation in the kidneys is more prominent in those patients with more severe CRF.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16825019     DOI: 10.1053/j.jrn.2006.04.020

Source DB:  PubMed          Journal:  J Ren Nutr        ISSN: 1051-2276            Impact factor:   3.655


  14 in total

1.  The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor.

Authors:  Jennifer C Schroeder; Brett C Dinatale; Iain A Murray; Colin A Flaveny; Qiang Liu; Elizabeth M Laurenzana; Jyh Ming Lin; Stephen C Strom; Curtis J Omiecinski; Shantu Amin; Gary H Perdew
Journal:  Biochemistry       Date:  2010-01-19       Impact factor: 3.162

2.  Ameliorative effect of chrysin on adenine-induced chronic kidney disease in rats.

Authors:  Badreldin H Ali; Sirin A Adham; Mohammed Al Za'abi; Mostafa I Waly; Javed Yasin; Abderrahim Nemmar; Nicole Schupp
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

3.  DPP-4 inhibitor attenuates toxic effects of indoxyl sulfate on kidney tubular cells.

Authors:  Wei-Jie Wang; Chen-Hung Chang; Mao-Feng Sun; Sheng-Feng Hsu; Ching-Sung Weng
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

4.  Indoxyl sulfate, a uremic toxin in chronic kidney disease, suppresses both bone formation and bone resorption.

Authors:  Kenta Watanabe; Tsukasa Tominari; Michiko Hirata; Chiho Matsumoto; Junya Hirata; Gillian Murphy; Hideaki Nagase; Chisato Miyaura; Masaki Inada
Journal:  FEBS Open Bio       Date:  2017-07-20       Impact factor: 2.693

5.  A novel SNP in the 5' regulatory region of organic anion transporter 1 is associated with chronic kidney disease.

Authors:  Chiao-Yin Sun; Mai-Szu Wu; Chin-Chan Lee; Shu-Hong Chen; Kang-Chieh Lo; Yau-Hung Chen
Journal:  Sci Rep       Date:  2018-05-24       Impact factor: 4.379

Review 6.  Aryl hydrocarbon receptor activation mediates kidney disease and renal cell carcinoma.

Authors:  Hui Zhao; Lin Chen; Tian Yang; Ya-Long Feng; Nosratola D Vaziri; Bao-Li Liu; Qing-Quan Liu; Yan Guo; Ying-Yong Zhao
Journal:  J Transl Med       Date:  2019-09-05       Impact factor: 5.531

Review 7.  Regulation of organic anion transporters: Role in physiology, pathophysiology, and drug elimination.

Authors:  Jinghui Zhang; Haoxun Wang; Yunzhou Fan; Zhou Yu; Guofeng You
Journal:  Pharmacol Ther       Date:  2020-08-03       Impact factor: 12.310

8.  Indoxyl sulfate down-regulates SLCO4C1 transporter through up-regulation of GATA3.

Authors:  Yasutoshi Akiyama; Koichi Kikuchi; Daisuke Saigusa; Takehiro Suzuki; Yoichi Takeuchi; Eikan Mishima; Yasuaki Yamamoto; Ayako Ishida; Daiki Sugawara; Daisuke Jinno; Hisato Shima; Takafumi Toyohara; Chitose Suzuki; Tomokazu Souma; Takashi Moriguchi; Yoshihisa Tomioka; Sadayoshi Ito; Takaaki Abe
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

Review 9.  Role of Uremic Toxins for Kidney, Cardiovascular, and Bone Dysfunction.

Authors:  Hideki Fujii; Shunsuke Goto; Masafumi Fukagawa
Journal:  Toxins (Basel)       Date:  2018-05-16       Impact factor: 4.546

10.  Paricalcitol attenuates indoxyl sulfate-induced apoptosis through the inhibition of MAPK, Akt, and NF-kB activation in HK-2 cells.

Authors:  Jung Sun Park; Hoon In Choi; Eun Hui Bae; Seong Kwon Ma; Soo Wan Kim
Journal:  Korean J Intern Med       Date:  2017-10-10       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.